About
Technology
Issues
FAQ
Links
Official Page
In Vivo
E2F Reporting Reveals Efficacious Schedules of MEK1/2–CDK4/6 Targeting and mTOR–S6 Resistance Mechanisms
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.